Because of these effects, GLP-1 has gained popularity in managing blood sugar and weight
On June 12, 2023, Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced that new findings for efinopegdutide (MK-6024), an investigational GLP-1/glucagon receptor co-agonist, have been accepted for oral presentation at the European Association for the Study of the Liver (EASL) Annual Congress from June 21-24
See the full ranked guides: However, to make the most of this mechanism, you must consume high-quality foods
Warm water or herbal tea first thing in the morning can kick-start peristalsis - the wave-like muscle contractions that push stool through your colon
[5] [6] Similarly, individuals with pre-existing fatigue, anaemia, or other comorbidities may find that GLP-1 therapy temporarily exacerbates their symptoms